{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:54:57Z","timestamp":1794048897381,"version":"4.8.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005963","name":"LAM Foundation","doi-asserted-by":"publisher","award":["LAM0161S05"],"award-info":[{"award-number":["LAM0161S05"]}],"id":[{"id":"10.13039\/100005963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease predominantly affecting women. Despite the availability of FDA-approved treatments, mTOR inhibitors like sirolimus or everolimus, significant disparities persist in early diagnosis, treatment utilization, and patient outcomes. The goal of this study is to examine how key socioeconomic factors affect diagnostic delay and treatment uptake in LAM. It was hypothesized that higher educational attainment is associated with earlier diagnosis and greater likelihood of treatment utilization due to its association with health literacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      To investigate the impact of socioeconomic factors, we analyzed data from the LAM Patient Research Priorities (LAM-PREP) study, a cross-sectional survey of LAM patients representing\u2009~\u200920% of known cases globally. 624 participants completed the survey and 566 provided complete education data and were therefore included in analyses. Multiple regression and logistic regression analyses were performed to examine the associations between educational attainment and diagnostic timing, as well as treatment utilization, controlling for age and disease severity. Among 566 patients with complete educational data, there was a 10-year average delay between self-reported symptom onset (mean age 25.0\u2009\u00b1\u200912.7 years) and diagnosis (mean age 35.1\u2009\u00b1\u200913.5 years). Educational attainment emerged as a significant predictor of diagnostic delay. Patients with bachelor\u2019s degrees were diagnosed 4.7 years earlier than those without a bachelor\u2019s degree (95% CI: -7.4 to -2.0,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Only 53% of patients reported using mTOR inhibitors. Educational attainment was a significant predictor of treatment utilization, with patients holding a bachelor\u2019s degree having 1.75 times higher adjusted odds of using mTOR inhibitors (AOR 1.75, 95% CI: 1.13\u20132.73,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013), and those with graduate degrees having 2.21 times higher odds (AOR 2.21, 95% CI: 1.41\u20133.45,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Educational attainment was significantly associated with both the timing of diagnosis and the likelihood of treatment uptake in LAM patients. These findings highlight the need for targeted interventions to address healthcare disparities in LAM care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04284-8","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:36:54Z","timestamp":1771828614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Educational attainment of individuals with lymphangioleiomyomatosis is a determinant of timely diagnosis and treatment uptake"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5030-7973","authenticated-orcid":false,"given":"Marina K.","family":"Holz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"2","key":"4284_CR1","doi-asserted-by":"publisher","first-page":"C320","DOI":"10.1152\/ajpcell.00202.2022","volume":"324","author":"N Kundu","year":"2023","unstructured":"Kundu N, Holz MK. Lymphangioleiomyomatosis: a metastatic lung disease. Am J Physiol Cell Physiol. 2023;324(2):C320\u20136.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"4284_CR2","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","volume":"9","author":"C McCarthy","year":"2021","unstructured":"McCarthy C, Gupta N, Johnson SR, Yu JJ, McCormack FX. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. Lancet Respir Med. 2021;9(11):1313\u201327.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"4284_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","volume":"194","author":"FX McCormack","year":"2016","unstructured":"McCormack FX, Gupta N, Finlay GR, Young LR, Taveira-DaSilva AM, Glasgow CG, et al. Official American Thoracic Society\/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management. Am J Respir Crit Care Med. 2016;194(6):748\u201361.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4284_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13023-025-03818-w","volume":"20","author":"S Briscoe","year":"2025","unstructured":"Briscoe S, Martin Pintado C, Sutcliffe K, Melendez-Torres GJ, Garside R, Lawal HM, et al. Evidence of inequities experienced by the rare disease community with respect to receipt of a diagnosis and access to services: a scoping review of UK and international evidence. Orphanet J Rare Dis. 2025;20(1):303.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4284_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s44162-025-00099-6","volume":"4","author":"A Chaudhary","year":"2025","unstructured":"Chaudhary A, Kumar V. Rare diseases: a comprehensive literature review and future directions. J Rare Dis. 2025;4(1):33.","journal-title":"J Rare Dis"},{"key":"4284_CR6","unstructured":"Coughlin SS, Vernon M, Hatzigeorgiou C, George V. Health Literacy, Social determinants of health, and disease prevention and control. J Environ Health Sci. 2020;6(1)."},{"issue":"1","key":"4284_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/10810730.2013.825668","volume":"18","author":"I van der Heide","year":"2013","unstructured":"van der Heide I, Wang J, Droomers M, Spreeuwenberg P, Rademakers J, Uiters E. The relationship between health, education, and health literacy: results from the Dutch Adult Literacy and Life Skills Survey. J Health Commun. 2013;18(1):172\u201384.","journal-title":"J Health Commun"},{"key":"4284_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chpulm.2025.100184","author":"MK Holz","year":"2025","unstructured":"Holz MK, Slattery AD, Pontz EJ, Dreyer SR, Downey GP, Gupta N, et al. Lymphangioleiomyomatosis (LAM) Patient Research Priorities (LAM-PREP): Developing a Patient-Centered Research Agenda. CHEST Pulmonary. 2025. https:\/\/doi.org\/10.1016\/j.chpulm.2025.100184.","journal-title":"CHEST Pulmonary"},{"issue":"4","key":"4284_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1164\/rccm.202310-1736LE","volume":"209","author":"E Lynn","year":"2024","unstructured":"Lynn E, Forde SH, Franciosi AN, Bendstrup E, Veltkamp M, Wind AE, et al. Updated Prevalence of Lymphangioleiomyomatosis in Europe. Am J Respir Crit Care Med. 2024;209(4):456\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"17","key":"4284_CR10","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011;364(17):1595\u2013606.","journal-title":"N Engl J Med"},{"key":"4284_CR11","doi-asserted-by":"publisher","first-page":"16027","DOI":"10.1038\/npjpcrm.2016.27","volume":"26","author":"O Hetlevik","year":"2016","unstructured":"Hetlevik O, Melbye H, Gjesdal S. GP utilisation by education level among adults with COPD or asthma: a cross-sectional register-based study. NPJ Prim Care Respir Med. 2016;26:16027.","journal-title":"NPJ Prim Care Respir Med"},{"issue":"4","key":"4284_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/HCR.0000000000000646","volume":"42","author":"DE Gaalema","year":"2022","unstructured":"Gaalema DE, Savage PD, O\u2019Neill S, Bolivar HA, Denkmann D, Priest JS, et al. The Association of Patient Educational Attainment With Cardiac Rehabilitation Adherence and Health Outcomes. J Cardiopulm Rehabil Prev. 2022;42(4):227\u201334.","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"4284_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.rmed.2016.09.007","volume":"119","author":"SS Tottenborg","year":"2016","unstructured":"Tottenborg SS, Lange P, Johnsen SP, Nielsen H, Ingebrigtsen TS, Thomsen RW. Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD. Respir Med. 2016;119:160\u20137.","journal-title":"Respir Med"},{"key":"4284_CR14","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2147\/COPD.S389379","volume":"18","author":"AC Barradell","year":"2023","unstructured":"Barradell AC, Robertson N, Houchen-Wolloff L, Singh SJ. Exploring the Presence of Implicit Bias Amongst Healthcare Professionals Who Refer Individuals Living with COPD to Pulmonary Rehabilitation with a Specific Focus Upon Smoking and Exercise. Int J Chron Obstruct Pulmon Dis. 2023;18:1287\u201399.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"4284_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.7812\/TPP\/11.979","volume":"15","author":"IV Blair","year":"2011","unstructured":"Blair IV, Steiner JF, Havranek EP. Unconscious (implicit) bias and health disparities: where do we go from here? Perm J. 2011;15(2):71\u20138.","journal-title":"Perm J"},{"issue":"1","key":"4284_CR16","doi-asserted-by":"publisher","first-page":"e214543","DOI":"10.1001\/jamahealthforum.2021.4543","volume":"3","author":"JB Segal","year":"2022","unstructured":"Segal JB, Sen AP, Glanzberg-Krainin E, Hutfless S. Factors Associated With Overuse of Health Care Within US Health Systems: A Cross-sectional Analysis of Medicare Beneficiaries From 2016 to 2018. JAMA Health Forum. 2022;3(1):e214543.","journal-title":"JAMA Health Forum"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04284-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04284-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04284-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:40:29Z","timestamp":1781635229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04284-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4284"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04284-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants. The study was reviewed and approved by the Institutional Review Board of New York Medical College (Protocol #20301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}